Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccinationShow others and affiliations
2022 (English)In: Blood, ISSN 0006-4971, E-ISSN 1528-0020, Vol. 140, no 22, p. 2403-2407Article in journal, Letter (Refereed) Published
Place, publisher, year, edition, pages
American Society of Hematology , 2022. Vol. 140, no 22, p. 2403-2407
National Category
Immunology in the medical area Infectious Medicine
Identifiers
URN: urn:nbn:se:kth:diva-323183DOI: 10.1182/blood.2022016815ISI: 000905121500008PubMedID: 36150168Scopus ID: 2-s2.0-85142728491OAI: oai:DiVA.org:kth-323183DiVA, id: diva2:1729893
Note
QC 20230123
2023-01-232023-01-232023-01-23Bibliographically approved